Multi-country

HER2 Testing Just Became the Gatekeeper in Gastroesophageal Cancer

MS Gets a Cleaner BTK Signal

Mpox Finally Gets A Stockpile

Brain Tumour Surgery Is Getting Smaller. Access Cannot Stay Elite.

AMR Has An Equity Problem

Novartis lowered Lp(a) but not cardiovascular risk. What went wrong?

Brain Tumour Surgery Is Getting Smaller. Access Cannot Stay Elite.

More than half had silent atherosclerosis. Standard risk scores missed many of them

AstraZeneca’s Wainua lowered a disease-causing protein but did not reduce heart complications in a major trial
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
